5-Methoxy-1,2,3,4-tetrahydronaphthalen-2-amine is an intermediate for Rotigotine (R700700), which is a non-ergot dopamine agonist drug and is indicated for the treatment of Parkinson’s disease.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.